Prana Announces that PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation July 17, 2013August 16, 2022
Alterity Therapeutics Initiates Second Phase 2 Study in Rare Parkinsonian Disorder May 30, 2023May 30, 2023